Grand Rounds, January 8, 2026

January 6, 2026

Presentation Title: Transcatheter Options for Mitral Valve Disease

Speaker: Abhijeet Dhoble, MD, M.B.B.S., MPH, RPVI, FACP, FACC, FSCAI – McGovern Medical School at UTHealth Houston

Date: Thursday, January 8, 2026
Time: 12:00 PM – 1:00 PM
Location: MSB 2.103
Learning Format: In-Person and Online

Series Objectives:

  • Apply the latest evidence with patients and practice evidence-based medicine.
  • Discuss current research and its potential for application to patient care.
  • Discuss the latest clinical practice guidelines relevant to clinical practice.

Learning Objectives:
At the conclusion of this activity, participants should be able to:

  • Identify the mechanisms and clinical implications of primary and secondary mitral regurgitation (MR).
  • Evaluate minimally invasive transcatheter therapies for mitral valve disease.
  • Apply evidence-based clinical decision-making for patient selection in MR and MS.

Credit Designation:

  • McGovern Medical School at the University of Texas Health Science Center at Houston designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • McGovern Medical School at the University of Texas Health Science Center at Houston designates this live activity for a maximum of 1 Hour(s) Attendance w/ No Credit. Participants should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Statement:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Event Disclosures:
Speakers:
Abhijeet Dhoble, MD, M.B.B.S., MPH, RPVI, FACP, FACC, FSCAI has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

  • Edwards Lifesciences – Speaking – Relationship Has Not Ended
  • Abbott – Speaking – Relationship Has Not Ended
  • Gore – Consulting – Relationship Has Not Ended

Any financial relationship that was found to be relevant has been mitigated.

Planners and other Administrative Support:
Tanvi Gupta, MD, Aastha V Bharwad, MD, Philip Orlander, MD, Mark A Farnie, MD, Robby Wesley, DO, FACP, Andrew Sullivan, MD, Gabriel Aisenberg, MD, Jeffrey Chen, MD, Carley Allen, MD, Sanjana M Rao, MD, and Karla Abela, PhD, RN, CCRN, CPN have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.

Commercial Support:
This activity is not commercially supported.

Accreditation Statement:
McGovern Medical School at the University of Texas Health Science Center at Houston is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

UTHealth Internal Medicine Grand Rounds
The Walter M. Kirkendall, MD and Margaret A. Kirkendall Annual Endowed Lecture Series

Related topics